<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
62037-605-08
</NDCCode>
<PackageDescription>
10638 TABLET, EXTENDED RELEASE in 1 BOX (62037-605-08)
</PackageDescription>
<NDC11Code>
62037-0605-08
</NDC11Code>
<ProductNDC>
62037-605
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Loratadine And Pseudoephedrine Sulfate
</NonProprietaryName>
<DosageFormName>
TABLET, EXTENDED RELEASE
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20030221
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Actavis Pharma, Inc.
</LabelerName>
<SubstanceName>
LORATADINE; PSEUDOEPHEDRINE SULFATE
</SubstanceName>
<StrengthNumber>
10; 240
</StrengthNumber>
<StrengthUnit>
mg/1; mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2021-01-01
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20211231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>